Corrigendum: Clinical and immunological effects of p53-targeting vaccines

Frontiers in Cell and Developmental Biology

Cell and Developmental Biology

Ken H. Young¹  Shan Zhou²  Yong Li²  Chunmei Fan³  Zhaoyang Zeng⁴ 

[1] Hematopathology Division, Department of Pathology, Duke University Medical Center, Durham, NC, United States;Section of Epidemiology and Population Science, Department of Medicine, Baylor College of Medicine, Houston, TX, United States;Section of Epidemiology and Population Science, Department of Medicine, Baylor College of Medicine, Houston, TX, United States;The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute and School of Basic Medicine, Central South University, Changsha, China;The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute and School of Basic Medicine, Central South University, Changsha, China;

关键词: p53;    vaccine;    Cancer;    immunotherapy;    T cell;   

DOI  :  10.3389/fcell.2023.1267661

 received in 2023-07-26, accepted in 2023-07-27,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Zhou, Fan, Zeng, Young and Li.